$1.35
-0.02-1.81%
At Close: -
$1.44
0.086.27%
After Hours: Jul 18, 9:08 AM EDT
15 minutes delayed
Enlivex Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Enlivex Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ENLV | Enlivex Therapeutics | -$0.32 | -$0.22 | — | — | $0.00 | — | — | — | 08/30/2024 | Get Alert |
ENLV | Enlivex Therapeutics | -$0.39 | -$0.28 | -$0.48 | -71.43% | $0.00 | — | $0.00 | — | 03/29/2024 | Get Alert |
ENLV | Enlivex Therapeutics | -$0.31 | -$0.39 | -$0.32 | 17.95% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
ENLV | Enlivex Therapeutics | -$0.54 | -$0.46 | -$0.37 | 1956.52% | $0.00 | — | $0.00 | — | 09/01/2023 | Get Alert |
ENLV | Enlivex Therapeutics | -$0.45 | — | -$0.39 | — | $0.00 | — | $0.00 | — | 06/16/2023 | Get Alert |
ENLV | Enlivex Therapeutics | -$0.27 | -$0.34 | -$0.39 | -14.71% | $0.00 | — | $0.00 | — | 04/10/2023 | Get Alert |
ENLV | Enlivex Therapeutics | -$0.19 | — | -$0.31 | — | $0.00 | — | $0.00 | — | 12/02/2022 | Get Alert |
ENLV | Enlivex Therapeutics | -$0.17 | — | -$0.54 | — | $0.00 | — | $0.00 | — | 08/22/2022 | Get Alert |
ENLV | Enlivex Therapeutics | -$0.19 | — | -$0.45 | — | $0.00 | — | $0.00 | — | 05/27/2022 | Get Alert |
ENLV | Enlivex Therapeutics | — | — | -$0.27 | — | — | — | $0.00 | — | 04/29/2022 | Get Alert |
ENLV | Enlivex Therapeutics | — | — | -$0.19 | — | — | — | $0.00 | — | 11/22/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-03-29 | $-0.48 | $-0.28 | -71.4 % |
Sep 2023 | 2023-11-09 | $-0.32 | $-0.39 | 17.9 % |
Jun 2023 | 2023-09-01 | $-0.37 | $-0.46 | 1956.5 % |
Mar 2023 | 2023-04-10 | $-0.39 | $-0.34 | -14.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Enlivex Therapeutics (ENLV) is scheduled to report earnings on August 30, 2024. The last reported earnings were for reported on March 29, 2024 for Q4.
The Actual EPS was $-0.48, which missed the estimate of $-0.28.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.